Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1998 Sep;15(9):1449-55.
doi: 10.1023/a:1011966024778.

Degradation kinetics of three gonadorelin analogues: developing a method for calculating epimerization parameters

Affiliations

Degradation kinetics of three gonadorelin analogues: developing a method for calculating epimerization parameters

M A Hoitink et al. Pharm Res. 1998 Sep.

Abstract

Purpose: To develop a method for calculating epimerisation parameters, find out if the kinetics of the independent reactions can be established, and elucidate primary structure-chemical degradation relationships in the degradation kinetics of three gonadorelin analogues.

Methods: The influences of pH, temperature, and buffer concentration on the degradation of the three gonadorelin analogues buserelin, goserelin, and triptorelin were investigated using RP-HPLC. A method was developed to calculate epimerisation and hydrolysis rate constants independently.

Results: Explicit structure-degradation mechanism relations were found in the degradation of all three compounds. The L-serine residue was found to be involved in both a solvent-catalysed backbone hydrolysis and a hydroxyl-catalysed epimerisation whereas, the O-tertiary butyl D-serine residue was only involved in proton-catalysed ether hydrolysis. The kinetics of identical reactions in different analogues were generally comparable.

Conclusions: The degradation of the gonadorelin analogues is located at a relatively small number of chemical residues and prediction of the degradation mechanisms and kinetics of other peptides with similar structural elements appears to be possible.

PubMed Disclaimer

References

    1. J Pharm Sci. 1991 May;80(5):419-23 - PubMed
    1. J Pharm Sci. 1991 Feb;80(2):167-70 - PubMed
    1. Chirality. 1993;5(3):105-11 - PubMed
    1. J Pharm Sci. 1996 Oct;85(10):1053-9 - PubMed

LinkOut - more resources